
Cholera still kills tens of thousands of people a year. Are you at risk?
Cholera still kills tens of thousands of people a year. Are you at risk?
Show Caption
Hide Caption
You Should Have 1 Of These 5 Drinks When You're Tired
Try one of these drinks to help boost your energy levels next time you're tired and struggling to function normally. Lemon water can not only help your digestion but also boost your energy levels. This is because lemons are high in potassium, which allows more oxygen to get to the brain and helps it function better. Beet juice is another good option, as it is rich in nitrates which may increase blood flow to the brain. Green tea has been used to boost energy levels for centuries. It contains caffeine and the amino acid L-Theanine. This amino acid can decrease anxiety and increase dopamine production. Berry smoothies are great for long-term brain health, as they're rich in antioxidants that protect the cells from damage. Hot chocolate can also help to boost energy levels. This is because cacao is rich in flavanols that can help boost cognitive function. It's best to use dark chocolate.
unbranded - Lifestyle
While cholera may have been killing people as far back as 400 B.C., it didn't start affecting the Americas until the second cholera pandemic began in 1829. Numerous other cholera pandemics followed, killing hundreds of thousands of people, including both the eleventh and twelfth presidents of the United States, James K. Polk and Zachary Taylor.
Today, cholera is a disease that largely impacts less developed and impoverished countries, "typically in regions of the world with poor infrastructure, conflict or displaced people who do not have access to the preventive measures that are needed such as safe drinking water and latrines," says Dr. Louise Ivers, director of the Harvard Global Health Institute at Harvard University.
In such places, cholera infects between one and four million people every year, per the World Health Organization, and contributes to some 21,000 to 143,000 deaths annually.
Here's what cholera is, what causes it and how it can be prevented and treated.
What is cholera?
Cholera is a bacterial infection of the intestines that leads to severe diarrhea and rapid dehydration, "which can quickly become life-threatening without treatment," says Dr. Jason Nagata, a pediatrician at UCSF Benioff Children's Hospital in San Francisco.
Other symptoms include vomiting, extreme thirst, fatigue, muscle cramps, dizziness "and the severe dehydration that can lead to death within hours without prompt treatment," says Nagata. Indeed, without treatment, research shows that cholera can be fatal in 30% to 50% of cases. "A perfectly healthy young adult can be working in the field in the morning and be dead by evening," explains Dr. David Sack, a professor in the international health department at Johns Hopkins Bloomberg School of Public Health.
The infected individual loses so much fluid and nutrients from the diarrhea and vomiting that they become severely dehydrated and experience organ failure as their systems go into shock.
At the same time, not everyone who is infected experiences a serious case of the disease and some people may pass the bacteria in their feces and have only mild symptoms or no symptoms at all.
Heads up: Tap water is generally safe to drink. But contamination can occur.
What causes cholera?
Cholera is caused by ingesting a bacteria known as Vibrio cholerae. It's found in contaminated water and food, explains Ivers, which then produces a toxin in the small intestine that leads to the severe diarrhea and rapid fluid loss.
Common sources of the bacteria "include raw shellfish and untreated water or food prepared with contaminated water," says Nagata. It's more common in poorer countries because often they lack running water or clean/filtered water, which can also become contaminated by ineffective or nonexistent plumbing.
In other words, "the feces and vomit from infected people can contaminate the water supply or the food and thereby transmit the disease to others," says Sack. What's more, he adds, "often people living in the same household and neighbors nearby are at higher risk because they may have been exposed to the same food or water source as the sick individual."
What causes dehydration? Here's how fluid loss can severely impact your health.
How is cholera prevented and treated?
The surest way to prevent cholera is by drinking safe water and eating food prepared with clean water. "It's also wise to avoid consuming raw or undercooked seafood and to follow proper sanitation and good hygiene practices," says Nagata. "And cholera vaccines are available for travelers to cholera-endemic areas," he adds. The FDA-approved vaccine is an oral one named Vaxchora, and the U.S. Centers for Disease Control and Prevention recommends getting it at least 10 days before traveling to an area of the world where cholera is present.
Cholera is treatable by drinking plenty of clean fluids or by getting such fluids intravenously. "Since dehydration is the primary problem, the treatment is rehydration," says Sack. He adds that antibiotics are also sometimes provided, "to shorten the purging and kill the bacteria to reduce the onward transmission of the disease." Prompt treatment like this "lowers the fatality rate of cholera to less than 1%," says Nagata.
While clean water and basic medical interventions are easy to provide in developed countries, "the challenge," Ivers says, "is that many of the people most at risk of cholera are also the same people with limited access to safe water or healthcare."
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 hours ago
- Yahoo
Why has there been a global surge of new Covid variant NB.1.8.1?
India is the latest country to report a surge in new Covid cases, as the latest variant NB.1.8.1 spreads across the globe. Cases have now been reported in Asian countries such as Thailand, Indonesia and China, while the UKHSA recorded the first 13 cases in England last week. However, the true numbers are unlikely to be known, given the significant decrease in the number of people testing compared to the figures seen during the global pandemic five years ago. NB.1.8.1 stemmed from the Omicron variant and was first detected in January this year. It has quickly spread across China and Hong Kong, and has now been recorded in several states across the United States and Australia. By late April, NB.1.8.1 comprised about 10.7 per cent of submitted sequences globally, according to the World Health Organization (WHO). This rose from just 2.5 per cent one month before. The WHO declared the NB.1.8.1 strain a 'variant under monitoring' on 23 May, which means scientists believe it could potentially affect the behaviour of the virus. Lara Herrero, a virologist from Griffith University in Australia, suspects that NB.1.8.1 spreads more easily than other variants. 'Using lab-based models, researchers found NB.1.8.1 had the strongest binding affinity to the human ACE2 receptor of several variants tested, suggesting it may infect cells more efficiently than earlier strains,' Dr Herrero wrote last month in The Conversation. Dr Chun Tang, GP at Pall Mall Medical, added: 'NB.1.8.1 isn't too different from the Omicron variant, but it does have some tweaks to its spike protein, which might make it spread a bit more easily or slip past some of our existing immunity. 'That said, early signs suggest it doesn't seem to cause more serious illness, but of course, we're still learning more about it.' 'Its spread has been identified in around 22 countries,' said Dr Naveed Asif, GP at The London General Practice. 'The WHO assesses the additional risk to the global public as currently low, and existing Covid-19 vaccines are considered effective in preventing severe disease.' However, Nimbus does appear to be more transmissible than previous variants, with notable increases reported in India, Hong Kong, Singapore, and Thailand, notes Dr Asif. Common symptoms of the NB.1.8.1 variant include a severe sore throat. fatigue, mild cough, fever, muscle aches and congestion. It has also been reported that some patients have experienced gastrointestinal symptoms such as nausea and diarrhoea. Healthcare experts have stressed, however, that there is no evidence that the new strain is more deadly or serious than previous variants, and that current Covid vaccines are expected to remain effective and protect anyone infected from severe illness.
Yahoo
2 days ago
- Yahoo
Man who let snakes bite him 200 times spurs new antivenom hope
Tim Friede was feeling particularly down on the day after the September 11 attacks, so he went to his basement and let two of the world's deadliest snakes bite him. Four days later, he woke up from a coma. "I know what it feels like to die from snakebite," Friede told AFP via video call from his home in the small US town of Two Rivers, Wisconsin. This experience might put most people off snakes entirely, but Friede simply vowed to be more careful next time. From 2000 to 2018, he allowed himself to be bitten by snakes more than 200 times. He also injected himself with their venom over 650 times. Friede endured this pain because he wanted to achieve total immunity to venom, a practice called mithridatism which should not be tried at home. After a couple of years, Friede started to believe he could be the basis for a better kind of antivenom. The former truck mechanic, who does not have a university degree, long struggled to be taken seriously by scientists. But last month, a study published in the prestigious Cell journal showed that antibodies from his blood protect against a range of snake venom. The researchers now hope Friede's hyper-immunity could even lead to the development of a universal antivenom. This would fill a major need, because currently most antivenoms only cover one or a few of the world's 600 venomous snakes. Up to 138,000 people are killed by snakebites a year, while 400,000 suffer amputations or other disabilities, according to the World Health Organization. These figures are believed to be vastly underestimated because snakebite victims typically live in poorer, remote areas. - 'Pain every time' - Friede's first bite was from a harmless garter snake when he was five years old. "I was afraid, I cried, I ran away," said Friede, now 57. Then he started bringing snakes home and hiding them in pickle jars. His mother sought counselling, but his interest in snakes persisted. Things escalated after Friede attended a class that taught him how to "milk" snakes for their venom. How antivenom is made has changed little over the last 125 years. Small doses of snake venom are injected into animals such as horses, which produce antibodies that can be extracted and used as antivenom. However this antivenom usually only works for bites from that particular species of snake -- and it includes other antibodies from horse that can cause serious side-effects including anaphylactic shock. "I thought, well, if they make antivenom in horses, why can't I just use myself as a primate?" Friede said. He started working through the venom from all the deadly species he could get his hands on, such as cobras, taipans, black mambas and rattlesnakes. "There is pain every time," he said. - 'Proud' - For years, the scientists he contacted to take advantage of his immunity refused to bite. Then in 2017, immunologist Jacob Glanville, who previously worked on universal vaccines, turned his attention towards antivenom. Glanville told AFP he had been looking for "a clumsy snake researcher who'd been bit accidentally a couple times," when he came across a video of Friede taking brutal back-to-back snake bites. When they first spoke, Glanville said he told Friede: "I know this is awkward, but I would love to get my hands on some of your blood." "I've been waiting for this call for a long time," came the response, Glanville said. The antivenom described in the Cell paper includes two antibodies from Friede's blood, as well as a drug called varespladib. It offered mice full protection against 13 of the 19 snake species tested, and partial protection for the remaining six. The researchers hope a future cocktail will cover far more snakes -- particularly vipers -- with further trials planned on dogs in Australia. Timothy Jackson of the Australian Venom Research Unit praised the immunological research, but questioned whether a human needed to be involved, pointing to synthetically developed antibodies. Glanville said the ultimate goal of his US-based firm Centivax was to develop a universal antivenom administered by something like an EpiPen, potentially produced in India to keep the costs down. Friede said he was "proud" to have made a "small difference" in medical history. Now working for Centivax, Friede stopped self-inflicting himself with venom in 2018 to save the firm from liability issues. But he hopes to get bitten by snakes again in the future. "I do miss it," he said. dl/giv
Yahoo
2 days ago
- Yahoo
Man who let snakes bite him 200 times spurs new antivenom hope
Tim Friede was feeling particularly down on the day after the September 11 attacks, so he went to his basement and let two of the world's deadliest snakes bite him. Four days later, he woke up from a coma. "I know what it feels like to die from snakebite," Friede told AFP via video call from his home in the small US town of Two Rivers, Wisconsin. This experience might put most people off snakes entirely, but Friede simply vowed to be more careful next time. From 2000 to 2018, he allowed himself to be bitten by snakes more than 200 times. He also injected himself with their venom over 650 times. Friede endured this pain because he wanted to achieve total immunity to venom, a practice called mithridatism which should not be tried at home. After a couple of years, Friede started to believe he could be the basis for a better kind of antivenom. The former truck mechanic, who does not have a university degree, long struggled to be taken seriously by scientists. But last month, a study published in the prestigious Cell journal showed that antibodies from his blood protect against a range of snake venom. The researchers now hope Friede's hyper-immunity could even lead to the development of a universal antivenom. This would fill a major need, because currently most antivenoms only cover one or a few of the world's 600 venomous snakes. Up to 138,000 people are killed by snakebites a year, while 400,000 suffer amputations or other disabilities, according to the World Health Organization. These figures are believed to be vastly underestimated because snakebite victims typically live in poorer, remote areas. - 'Pain every time' - Friede's first bite was from a harmless garter snake when he was five years old. "I was afraid, I cried, I ran away," said Friede, now 57. Then he started bringing snakes home and hiding them in pickle jars. His mother sought counselling, but his interest in snakes persisted. Things escalated after Friede attended a class that taught him how to "milk" snakes for their venom. How antivenom is made has changed little over the last 125 years. Small doses of snake venom are injected into animals such as horses, which produce antibodies that can be extracted and used as antivenom. However this antivenom usually only works for bites from that particular species of snake -- and it includes other antibodies from horse that can cause serious side-effects including anaphylactic shock. "I thought, well, if they make antivenom in horses, why can't I just use myself as a primate?" Friede said. He started working through the venom from all the deadly species he could get his hands on, such as cobras, taipans, black mambas and rattlesnakes. "There is pain every time," he said. - 'Proud' - For years, the scientists he contacted to take advantage of his immunity refused to bite. Then in 2017, immunologist Jacob Glanville, who previously worked on universal vaccines, turned his attention towards antivenom. Glanville told AFP he had been looking for "a clumsy snake researcher who'd been bit accidentally a couple times," when he came across a video of Friede taking brutal back-to-back snake bites. When they first spoke, Glanville said he told Friede: "I know this is awkward, but I would love to get my hands on some of your blood." "I've been waiting for this call for a long time," came the response, Glanville said. The antivenom described in the Cell paper includes two antibodies from Friede's blood, as well as a drug called varespladib. It offered mice full protection against 13 of the 19 snake species tested, and partial protection for the remaining six. The researchers hope a future cocktail will cover far more snakes -- particularly vipers -- with further trials planned on dogs in Australia. Timothy Jackson of the Australian Venom Research Unit praised the immunological research, but questioned whether a human needed to be involved, pointing to synthetically developed antibodies. Glanville said the ultimate goal of his US-based firm Centivax was to develop a universal antivenom administered by something like an EpiPen, potentially produced in India to keep the costs down. Friede said he was "proud" to have made a "small difference" in medical history. Now working for Centivax, Friede stopped self-inflicting himself with venom in 2018 to save the firm from liability issues. But he hopes to get bitten by snakes again in the future. "I do miss it," he said. dl/giv